Churchill Downs Incorporated 2024 Third Quarter Financial Results Conference Call Invitation
September 20, 2024 16:01 ET
|
Churchill Downs Incorporated
LOUISVILLE, Ky., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release third quarter 2024 financial results after the...
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 20, 2024 16:01 ET
|
Sutro Biopharma, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...
Gaxos.ai Inc. Announces Exercise of Warrants for $3.24 Million Gross Proceeds
September 20, 2024 14:58 ET
|
GAXOS.AI INC.
Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today...
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
September 20, 2024 14:55 ET
|
FutureTech II Acquisition Corp.
-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of...
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
September 20, 2024 12:08 ET
|
Zevra Therapeutics
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative diseaseMIPLYFFA is indicated for use in combination with miglustat...
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
September 20, 2024 11:59 ET
|
Trxade Health, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced...
Hanover Bank Hosts Celebration to Thank Community
September 20, 2024 11:48 ET
|
Hanover Bancorp, Inc
Hanover Bank Hosts Celebration to Thank Community
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
September 20, 2024 11:45 ET
|
Onconetix, Inc.
CINCINNATI, Ohio, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and...
ハット8 (Hut 8) とビットメイン (BITMAIN)、次世代ビットメインマイナーの発売によりイノベーションパートナーシップを拡大
September 20, 2024 11:37 ET
|
Hut 8 Corp.
ビットメインが量産する初のASICマイナーとなるU3S21EXPHモデルは、Uフォームファクター内のダイレクトチップ液体冷却機能を採用 ハット8は、購入オプションによるセルフマイニングへの移行も可能な、約15 EH/sのホスティング展開を通じて、2025年第2四半期にモデルを展開する予定 マイアミ発, Sept. 21, 2024 (GLOBE NEWSWIRE) --...
Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
September 20, 2024 11:20 ET
|
Psyence Group Inc.
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) (as seller), a life science biotechnology company pioneering the use of nature-derived...